A genome-wide RNA interference screen identifies caspase 4 as a factor required for tumor necrosis factor alpha

Dorothee Nickles1, Christina Falschlehner, Marie Metzig

  • 1German Cancer Research Center (DKFZ), Division of Signaling and Functional Genomics, and Heidelberg University, Department of Cell and Molecular Biology, Medical Faculty Mannheim, Heidelberg, Germany.

Insights

Researchers identified caspase 4 as a novel regulator of tumor necrosis factor alpha (TNF-α) signaling. This finding advances understanding of inflammatory pathways and potential therapeutic targets for diseases linked to TNF-α.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Tumor necrosis factor alpha (TNF-α) is a key inflammatory cytokine involved in diseases like cancer.
  • TNF-α signaling is crucial in cellular stress and immune responses.
  • While TNF-α pathway signaling is partially understood, novel regulators are continuously sought.

Purpose of the Study:

  • To identify novel regulators of pro-inflammatory signaling induced by TNF-α.
  • To elucidate the complete compendium of factors involved in TNF-α signal transduction.
  • To investigate the role of specific identified factors in TNF-α signaling pathways.

Main Methods:

  • Genome-wide small interfering RNA (siRNA) screen in human cells.
  • Confirmation of candidate modulators through independent experiments.
  • Analysis of specific signaling branches, including NF-κB and Jun N-terminal protein kinase (JNK).

Main Results:

  • Identification of several new candidate modulators of TNF-α signaling.
  • Caspase 4 was identified as essential for NF-κB activity induction.
  • Caspase 4 was found to be dispensable for JNK signaling activation.

Conclusions:

  • Caspase 4 is a novel regulator of TNF-α-induced NF-κB signaling.
  • Caspase 4 is required for the activation of IκB kinase in the TNF-α pathway.
  • The study provides a genome-wide RNA interference dataset for future research.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...